user

Vcanbio Cell & Gene Engineering Corporation

Biotechnology Research
  • image
    Shiying Zhang Bioinformatics Analyst
    • Binhai, Tianjin, China
    • Rising Star
    View Details
  • image
    Guangzhao Li Vcanbio Cell & Gene Engineering Corporation - Lab Supervisor
    • Dongli District, Tianjin, China
    • Top 10%
    View Details
  • image
    hongtao li Principal scientist at Imanis Life Science
    • Rochester, Minnesota, United States
    • Rising Star
    View Details
  • image
    Jiaoqing Wang Vcanbio Cell & Gene Engineering Corporation - Manager
    • London, England, United Kingdom
    • Rising Star
    View Details
  • image
    Ray Tian VP Product Development at Vcanbio Cell & Gene Engineering Corporation
    • Natick, Massachusetts, United States
    • Rising Star
    View Details

Overview

VCANBIO Cell & Gene Engineering Corporation, Ltd (also named Zhongyuan Union) is the only company which has its main business in cell and gene engineering industry and listed in domestic Shanghai stock market with code 600645 in China. VCANBIO is also one of the first companies investing biological resources storage. Zhongyuan Union is the deputy director of the National Strategic Alliance for Technical Innovation of Stem Cell and Regenerative Medicine Industry and has carried the project in building the national stem cell and gene clinical translational base. Meanwhile, it operates the Tianjin Cord Blood Bank, one of the largest cord blood banks with over 300000 storage samples in the world. After 15 year successful development, VCANBIO has operated several well-known affiliated companies, including Union Stem Cell & Gene Engineering Co., Ltd., Alliancells Bioscience Co., Ltd., Zhongyuan Union Gene Technology Co., Ltd., Zhongyuan Pharma Co., Ltd., and Shanghai Zhicheng Biological Technology Co., Ltd. At present, the Company has set up branch companies covering 25 provinces in China, provides the whole industrial chain products and services in cell and gene industry. Its current market value reaches 23 billion RMB.